Sign inJoin waitlistJoin the waitlist

Dionisia Quiroga

Hematology & Oncology · Osu Internal Medicine, LLC

Credentials: · · · ·

History

Michigan State University
2016
Michigan State University
2007

Research

Triple-negative breast cancer: promising prognostic biomarkers currently in development
Review · Expert Review of Anticancer Therapy · 2021 · 185 citations
Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development
Systematic review or meta-analysis · Drug Designing Open Access · 2020 · 147 citations
Endoplasmic reticulum aminopeptidase-1 alleles associated with increased risk of ankylosing spondylitis reduce HLA-B27 mediated presentation of multiple antigens
Autoimmunity · 2013 · 52 citations

Robert Wesolowski
22 papers
Daniel Stover
16 papers
Margaret Gatti-Mays
13 papers
Nicole Williams
13 papers
Sagar Sardesai
13 papers
AD
Ashley Davenport
12 papers · 1 as a fellow
KJ
Kai Johnson
12 papers · 2 as a fellow
Matthew Cherian
12 papers
William Carson
12 papers
Maryam Lustberg
9 papers
BR
Bhuvaneswari Ramaswamy
7 papers
Andrea Amalfitano
6 papers

Clinical trials

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2023–2032
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2023–2033